Can synthetic datasets bridge biology's sim2real gap for breakthroughs?

Synthetic datasets offer a promising way to simulate complex biological phenomena under controlled conditions. However, their full potential remains limited by significant challenges, including the sim2real gap and computational hurdles. The scientific community uses synthetic data to model biological processes with designed parameters. Yet, capturing the full complexity of these phenomena is difficult due to the many influencing factors. This complexity creates a persistent discrepancy between simulations and real-world outcomes, known as the sim2real gap.

To address this, researchers call for multilayered validation frameworks. They also stress the need for domain adaptation and hybrid validation to test models in both simulated and real biological contexts. Deep collaboration between computer scientists, biologists, and clinicians is essential to achieve biological realism in these datasets.

The path forward is not without obstacles. Computational demands and the need for standardised parameters add to the difficulty. Data scarcity further hampers progress in machine learning for biomedical research. Closing the sim2real gap could unlock major advances, such as digital twins for personalised medicine and faster therapeutic discovery. However, overcoming computational and biological challenges will be critical to realising these benefits. The scientific community continues to push for solutions to make synthetic data more reliable and applicable.